Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | November 28, 2022 12:32pm

Gainers

  • NanoVibronix (NASDAQ:NAOV) shares rose 59.9% to $0.41 during Monday's regular session. The current volume of 8.6 million shares is 2424.3% of NanoVibronix's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $11.5 million.
  • Talkspace (NASDAQ:TALK) stock rose 36.96% to $0.82. As of 12:30 EST, this security is trading at a volume of 9.7 million shares, making up 1768.1% of its average full-day volume over the last 100 days. The company's market cap stands at $130.7 million.
  • Axsome Therapeutics (NASDAQ:AXSM) stock increased by 31.67% to $74.82. The current volume of 7.7 million shares is 596.3% of Axsome Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $3.2 billion.
  • Cosmos Holdings (NASDAQ:COSM) stock rose 27.2% to $0.55. Cosmos Holdings's stock is trading at a volume of 129.1 million shares as of 12:30 EST. This is 441.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $45.7 million.
  • Tricida (NASDAQ:TCDA) stock increased by 22.06% to $0.25. Trading volume for Tricida's stock is 30.5 million as of 12:30 EST. This is 361.5% of its average full-day volume over the last 100 days. The company's market cap stands at $14.5 million.
  • IO Biotech (NASDAQ:IOBT) stock rose 20.5% to $3.25. The current volume of 56.7K shares is 85.6% of IO Biotech's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $93.7 million.

Losers

  • CinCor Pharma (NASDAQ:CINC) stock declined by 42.9% to $15.16 during Monday's regular session. CinCor Pharma's stock is trading at a volume of 2.0 million shares as of 12:30 EST. This is 723.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $663.4 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) shares fell 30.73% to $4.69. As of 12:30 EST, this security is trading at a volume of 69.3K shares, making up 522.4% of its average full-day volume over the last 100 days. The company's market cap stands at $186.4 million.
  • OncoSec Medical (NASDAQ:ONCS) stock declined by 24.11% to $2.56. Trading volume for OncoSec Medical's stock is 389.0K as of 12:30 EST. This is 130.4% of its average full-day volume over the last 100 days. The company's market cap stands at $4.5 million.
  • Peak Bio (NASDAQ:PKBO) shares declined by 21.09% to $5.13. Peak Bio's stock is trading at a volume of 55.5K shares as of 12:30 EST. This is 4.3% of its average full-day volume over the last 100 days. The company's market cap stands at $102.8 million.
  • TransCode Therapeutics (NASDAQ:RNAZ) shares decreased by 18.17% to $0.4. The current volume of 290.8K shares is 43.9% of TransCode Therapeutics's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $5.1 million.
  • Anavex Life Sciences (NASDAQ:AVXL) shares declined by 15.98% to $9.99. As of 12:30 EST, this security is trading at a volume of 2.0 million shares, making up 232.2% of its average full-day volume over the last 100 days. The company's market cap stands at $778.6 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AVXL AXSM CINC COSM IOBT NAOV ONCS PKBO RNAZ TALK TCBP TCDA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist